Since tumor angiogenesis is responsible for gastrointestinal tumor growth, metastasis, and survival, the simultaneous inhibition of tumor-driven angiogenesis mediated by angiogenins and vascular endothelial growth factors would represent one of the major therapeutic approach against cancer. The gene discussed is ANG; the disease is neoplasm.